Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Central nervous system (CNS) receptors are a vast and heterogeneous group of integral membrane proteins located on neurons and glial cells throughout the brain and spinal cord (StatPearls: Neuroanatomy, Central Nervous System, 2023). They serve as the primary mediators of chemical communication in the nervous system by binding to specific ligands such as neurotransmitters, neuropeptides, and hormones (NIH: Brain Basics: The Life and Death of a Neuron). These receptors are broadly classified into two functional categories: ionotropic receptors, which are ligand-gated ion channels that facilitate rapid electrical signaling, and metabotropic receptors, which are G protein-coupled receptors (GPCRs) that initiate slower, more sustained intracellular biochemical changes (IUPHAR/BPS Guide to Pharmacology). Because they regulate essential processes ranging from basic motor reflexes to complex cognitive functions, their dysfunction is a hallmark of numerous neurological and psychiatric conditions, including Alzheimer's disease, schizophrenia, and epilepsy (PubMed: CNS Receptor Dysregulation). Consequently, they are among the most important targets in pharmacology, though drug development is often hindered by the challenge of achieving blood-brain barrier penetration and avoiding off-target effects within the highly interconnected neural circuitry (PubChem: Neuropharmacology).
Drugs targeting these receptors typically act via agonism, antagonism, or allosteric modulation to increase or decrease neuronal excitability and downstream intracellular signaling pathways (StatPearls: Neurotransmission, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system receptors (CNS receptors).